The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
σ-1 Receptors (σ1 Binding Sites) Form Raft-Like Microdomains and Target Lipid Droplets on the Endoplasmic Reticulum: Roles in Endoplasmic Reticulum Lipid Compartmentalization and Export
Abstract
The brain sigma-1 receptors can bind neurosteroids and psychotropic drugs, including neuroleptics and cocaine and are implicated in schizophrenia, depression, and drug dependence. In this study, we found that sigma-1 receptors specifically target lipid storage sites (lipid droplets) on the endoplasmic reticulum by forming a distinct class of lipid microdomains. Both endogenously expressing sigma-1 receptors and transfected C-terminally enhanced yellow fluorescent protein (EYFP)-tagged sigma-1 receptors (Sig-1R-EYFP) target unique "ring-like" structures associated with endoplasmic reticulum reticular networks in NG108-15 cells. The ring-like structures contain neutral lipids and are enlarged by the oleate treatment, indicating that they are endoplasmic reticulum-associated lipid droplets (ER-LDs). sigma-1 receptors colocalize with caveolin-2, a cholesterol-binding protein in lipid rafts on the ER-LDs, but not with adipocyte differentiation-related protein (ADRP), a cytosolic lipid droplet (c-LD)-specific protein. When the double-arginine ER retention signal on the N terminus of sigma-1 receptors is truncated, sigma-1 receptors no longer exist on ER-LDs, but predominantly target c-LDs, which contain ADRP. sigma-1 receptors on ER-LDs form detergent-resistant raft-like lipid microdomains, the buoyancy of which is different from that of plasma membrane lipid rafts. (+)-Pentazocine causes sigma-1 receptors to disappear from the microdomains. N-Terminally EYFP-tagged sigma-1 receptors (EYFP-Sig-1R) failed to target ER-LDs. EYFP-Sig-1R-transfected cells showed an unrestricted distribution of neutral lipids all over the endoplasmic reticulum network, decreases in c-LDs and cholesterol in plasma membranes, and the bulbous aggregation of endoplasmic reticulum. Thus, sigma-1 receptors are unique endoplasmic reticulum proteins that regulate the compartmentalization of lipids on the endoplasmic reticulum and their export from the endoplasmic reticulum to plasma membrane and c-LDs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, SIGMAR1 appears to promote the compartmentalization of cholesterol in ER membranes (158), although depletion of cholesterol promoted mitochondrial–ER association in in vitro membrane association assays and cell models (159).”
From Adrenal Mitochondria and Steroidogenesis: From Individual Proteins to Functional Protein Assemblies (2016) · cites this paper as [158]
Citations
Cites
Lipid rafts and signal transduction
Simons, K., & Toomre, D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036052 · Cited by 5,371
Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., & Gilbert, P. E. (1976) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30536-7 · Cited by 2,992
Anderson, R. G. W. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.199 · Cited by 1,941
Purification, molecular cloning, and expression of the mammalian sigma1-binding site.
Hanner, M., Moebius, F. F., Flandorfer, A., Knaus, H. G., Striessnig, J., Kempner, E. S., & Glossmann, H. H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.8072 · Cited by 914
Cholesterol metabolism in the brain
Dietschy, J. M., & Turley, S. D. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200104000-00003 · Cited by 906
The Surface of Lipid Droplets Is a Phospholipid Monolayer with a Unique Fatty Acid Composition
Tauchi-Sato, K., Ozeki, S., Houjou, T., Taguchi, R., & Fujimoto, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207712200 · Cited by 753
Brasaemle, D., Barber, T., Wolins, N. E., Serrero, G., Blanchette‐Mackie, E. J., & Londos, C. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34939-7 · Cited by 644
Mechanisms of lipid-body formation
Murphy, D. J., & Vance, J. E. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01349-8 · Cited by 577
Steroid Binding at σ Receptors Suggests a Link Between Endocrine, Nervous, and Immune Systems
Su, T., London, E. D., & Jaffe, J. H. (1988) · Science · doi:10.1126/science.2832949 · Cited by 548
Self-citationSu, T.-P. (1982) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33330-6 · Cited by 435
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 270
Epidermal Growth Factor-induced Vacuolar (H+)-ATPase Assembly
Xu, Y., Parmar, A., Roux, E., Balbis, A., Dumas, V., Chevalier, S., & Posner, B. I. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.352229 · Cited by 59
Access of viral proteins to mitochondria via mitochondria‐associated membranes
Williamson, C. D., & Colberg‐Poley, A. M. (2009) · Reviews in Medical Virology · doi:10.1002/rmv.611 · Cited by 63
Molecular Dysfunctions of Mitochondria-Associated Membranes (MAMs) in Alzheimer’s Disease
Eysert, F., Kinoshita, P. F., Mary, A., Vaillant-Beuchot, L., Checler, F., & Chami, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249521 · Cited by 63
Niso, M., Abate, C., Contino, M., Ferorelli, S., Azzariti, A., Perrone, R., Colabufo, N. A., & Berardi, F. (2013) · ChemMedChem · doi:10.1002/cmdc.201300291 · Cited by 60
Chevallier, N., Keller, E., & Maurice, T. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111400648 · Cited by 60
Matsumoto, R. R., Shaikh, J., Wilson, L., Vedam, S., & Coop, A. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.07.006 · Cited by 56
Pal, A., Chu, U. B., Ramachandran, S., Grawoig, D., Guo, L., Hajipour, A. R., & Ruoho, A. E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802192200 · Cited by 56
A Variant of the Sigma Receptor Type-1 Gene Is a Protective Factor for Alzheimer Disease
Uchida, N., Ujike, H., Tanaka, Y., Sakai, A., Yamamoto, M., Fujisawa, Y., Kanzaki, A., & Kuroda, S. (2005) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200512000-00005 · Cited by 56
Dysregulation of Neuronal Calcium Signaling via Store-Operated Channels in Huntington's Disease
Czeredys, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.611735 · Cited by 56
Wu, N., Ye, Y., Wan, B.-B., Yu, Y.-D., Liu, C., & Chen, Q. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02524-5 · Cited by 55
Cocaine and HIV-1 Interplay: Molecular Mechanisms of Action and Addiction
Buch, S. J., Yao, H., Guo, M., Mori, T., Su, T., & Wang, J. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9297-0 · Cited by 55
Self-citationAbate, C., Niso, M., Lacivita, E., Mosier, P. D., Toscano, A., & Perrone, R. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013133 · Cited by 55
Wang, J., Zhao, J., Cui, X., Mysona, B. A., Navneet, S., SAUL, A. B., Ahuja, M., Lambert, N. A., Gazaryan, I. G., Thomas, B., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.02.001 · Cited by 51
Friesland, M., Mingorance, L., Chung, J., Chisari, F. V., & Gastaminza, P. (2013) · Journal of Virology · doi:10.1128/jvi.03557-12 · Cited by 51
Zhemkov, V., Geva, M., Hayden, M. R., & Борисович, Б. И. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084082 · Cited by 50
Harada, T., Sada, R., Osugi, Y., Matsumoto, S., Matsuda, T., Hayashi, M., Nagai, T., Harada, A., & Kikuchi, A. (2020) · Journal of Cell Science · doi:10.1242/jcs.249045 · Cited by 49
Antinociception by Sigma-1 Receptor Antagonists
Romero, L. I., Merlos, M., & Vela, J. M. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2015.11.003 · Cited by 47
Ligand-dependent localization and intracellular stability of sigma-1 receptors in CHO-K1 ce
Mavlyutov, T. A., & Ruoho, A. E. (2007) · Journal of Molecular Signaling · doi:10.1186/1750-2187-2-8 · Cited by 48
Immunohistochemical localization of the sigma1 receptor in Schwann cells of rat sciatic nerve
Palacios, G., Muro, A., Verdú, E., Pumarola, M. B., & Vela, J. M. (2004) · Brain Research · doi:10.1016/j.brainres.2004.02.013 · Cited by 48
Ruscher, K., Inácio, A. R. L., Valind, K., Ravan, A. R., Kuric, E., & Wieloch, T. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045118 · Cited by 50
Regulators of mitochondrial Ca2+ homeostasis in cerebral ischemia
Schäfer, M. K. E., Pfeiffer, A., Jaeckel, M., Pouya, A., Dolga, A. M., & Methner, A. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1807-y · Cited by 47
The Functional Role of Voltage-Gated Sodium Channel Nav1.5 in Metastatic Breast Cancer
Luo, Q., Wu, T., Wu, W., Chen, G., Luo, X., Jiang, L., Tao, H., Rong, M., Kang, S., & Deng, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01111 · Cited by 46
Structure of the σ1 Receptor and Its Ligand Binding Site
Brune, S., Pricl, S., & Wünsch, B. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400660u · Cited by 46
ADRP is dissociated from lipid droplets by ARF1-dependent mechanism
Nakamura, N., Akashi, T., Taneda, T., Kogo, H., Kikuchi, A., & Fujimoto, T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.010 · Cited by 46
Ramachandran, S., Lu, H., Prabhu, U., & Ruoho, A. E. (2006) · Protein Expression and Purification · doi:10.1016/j.pep.2006.07.019 · Cited by 45
Overview of Sigma-1R Subcellular Specific Biological Functions and Role in Neuroprotection
Lachance, V., Bélanger, S.-M., Hay, C., Corvec, V. L., Banouvong, V., Lapalme, M., Tarmoun, K., Beaucaire, G., Lussier, M. P., & Kourrich, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031971 · Cited by 46
Dam, D. V., Coen, K., & Deyn, P. P. D. (2007) · Psychopharmacology · doi:10.1007/s00213-007-1010-x · Cited by 44
Simmen, T., & Tagaya, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-4567-7_1 · Cited by 43
Hornung, R. S., Benton, W. L., Tongkhuya, S. A., Uphouse, L. L., Kramer, P. R., & Averitt, D. L. (2020) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2020.00026 · Cited by 43
Cancer: Untethering Mitochondria from the Endoplasmic Reticulum?
Herrera-Cruz, M. S., & Simmen, T. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00105 · Cited by 45
Targeting Nanocarriers with Anisamide: Fact or Artifact?
Dasargyri, A., Kümin, C. D., & Leroux, J. (2016) · Advanced Materials · doi:10.1002/adma.201603451 · Cited by 41
Mavylutov, T., Chen, X., Guo, L., & Yang, J. (2017) · Protein & Cell · doi:10.1007/s13238-017-0468-5 · Cited by 41
Procino, G., Barbieri, C., Carmosino, M., Rizzo, F., Valenti, G., & Svelto, M. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00359.2009 · Cited by 41
The evolutionary appearance of signaling motifs in PGRMC1
Cahill, M. A. (2017) · BioScience Trends · doi:10.5582/bst.2017.01009 · Cited by 40
Vidal‐Torres, A., Fernández‐Pastor, B., Carceller, A., Vela, J. M., Merlos, M., & Zamanillo, D. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12648 · Cited by 40
Circulating low density lipoprotein (LDL)
Khosravi, M., Hosseini‐Fard, S. R., & Najafi, M. (2018) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2018-0024 · Cited by 41
Chaperone Sigma1R and Antidepressant Effect
Воронин, М. В., Vakhitova, Y. V., & Середенин, С. Б. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197088 · Cited by 41
Prasanth, M. I., Malar, D. S., Tencomnao, T., & Brimson, J. M. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1939681 · Cited by 40
The Human Cytomegalovirus Protein UL37 Exon 1 Associates with Internal Lipid Rafts
Williamson, C. D., Zhang, A., & Colberg‐Poley, A. M. (2010) · Journal of Virology · doi:10.1128/jvi.01830-10 · Cited by 38
A role for sigma receptors in stimulant self-administration and addiction
Katz, J. L., Hong, W. C., Hiranita, T., & Su, T. (2015) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000209 · Cited by 38
Self-citationMunguía-Galaviz, F. J., Miranda‐Díaz, A. G., Cárdenas-Sosa, M. A., & Echavarría, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031997 · Cited by 40
Loss of Sigma‐1 Receptor Chaperone Promotes Astrocytosis and Enhances the Nrf2 Antioxidant Defense
Weng, T.-Y., Hung, D. T., Su, T., & Tsai, S. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/4582135 · Cited by 38
Self-citationSigma-1 receptors and animal studies centered on pain and analgesia
Davis, M. P. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1051961 · Cited by 35
Ruoho, A. E., Chu, U. B., Ramachandran, S., Fontanilla, D., Mavlyutov, T. A., & Hajipour, A. R. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799436584 · Cited by 35
Connection Lost, MAM: Errors in ER–Mitochondria Connections in Neurodegenerative Diseases
Johri, A., & Chandra, A. (2021) · Brain Sciences · doi:10.3390/brainsci11111437 · Cited by 34
Cormaci, G., Mori, T., Hayashi, T., & Su, T. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.108415 · Cited by 34
Self-citationDugail, I., Amri, E., & Vitale, N. (2020) · Biochimie · doi:10.1016/j.biochi.2020.07.001 · Cited by 34
Liu, D., Yang, L., Liu, P., Ji, X., Qi, X., Wang, Z., Chi, T., & Zou, L. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113867 · Cited by 33
Espallergues, J., Lapalud, P., Christopoulos, A., Avlani, V. A., Sexton, P. M., Vamvakides, A., & Maurice, T. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707386 · Cited by 33
Ellis, D. Z., Li, L., Park, Y. H., He, S., Mueller, B., & Yorio, T. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19199 · Cited by 33
Sigma 1 Receptor and Its Pivotal Role in Neurological Disorders
Shokr, M. M., Badawi, G. A., Elshazly, S. M., Zaki, H. F., & Mohamed, A. F. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00564 · Cited by 33
Trafficking of PrPcto mitochondrial raft-like microdomains during cell apoptosis
Sorice, M., Mattei, V., Tasciotti, V., Manganelli, V., Garofalo, T., & Misasi, R. (2012) · Prion · doi:10.4161/pri.20479 · Cited by 32
Alamri, M. A. (2019) · Bioinformation · doi:10.6026/97320630015586 · Cited by 32
Shenkman, M., Geva, M., Gershoni‐Emek, N., Hayden, M. R., & Lederkremer, G. Z. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15366 · Cited by 31
Endomembrane remodeling in SARS-CoV-2 infection
Chen, D., Zhao, Y. G., & Zhang, H. (2022) · Cell Insight · doi:10.1016/j.cellin.2022.100031 · Cited by 33
Yin, J., Sha, S., Chen, T., Wang, C., Hong, J., Jie, P., Zhou, R., Li, L., Sokabe, M., & Chen, L. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.09.027 · Cited by 30
Aberrant Subcellular Dynamics of Sigma-1 Receptor Mutants Underlying Neuromuscular Diseases
Wong, A. Y. C., Hristova, E., Ahlskog, N., Tassé, L.-A., Ngsee, J. K., Chudalayandi, P., & Bergeron, R. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.104018 · Cited by 30
Soriani, O., & Kourrich, S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01186 · Cited by 29
Dasargyri, A., Hervella, P., Christiansen, A. J., Proulx, S. T., Detmar, M. J., & Leroux, J. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.021 · Cited by 29
The Sigma Enigma: A Narrative Review of Sigma Receptors
Pergolizzi, J. V., Varrassi, G., Coleman, M., Breve, F., Christo, D. K., Christo, P. J., & Moussa, C. (2023) · Cureus · doi:10.7759/cureus.35756 · Cited by 29
Fu, Y., Zhao, Y., Luan, W., Dong, L.-Y., Dong, Y. W., Lai, B., Zhu, Y., & Zheng, P. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.08.005 · Cited by 28
Franchini, S., Battisti, U. M., Prandi, A., Tait, A., Borsari, C., Cichero, E., Fossa, P., Cilia, A., Prezzavento, O., Ronsisvalle, S., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.01.059 · Cited by 27
Ma, H., Li, J., Qiao, X., Zhang, Y., Hou, X.-J., Chen, H., Chen, H., Zhang, Y., & Li, Y. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01201-8 · Cited by 28
Nhu, H., Nguyen, L. T. T., Shin, E., Kim, D.-J., Jeong, J. H., Chung, Y. H., Lei, X. G., Sharma, N., Jang, C., Nabeshima, T., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.12.027 · Cited by 27
Interaction of Afobazole with σ1-Receptors
Середенин, С. Б., Антипова, Т. А., Воронин, М. В., Kurchashova, S., & Kuimov, A. N. (2009) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-009-0624-x · Cited by 26
The essential roles of protein–protein interaction in sigma-1 receptor functions
Pabba, M. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00050 · Cited by 25
Xu, Q., Li, E., Zhang, Y.-F., Liao, L., Xu, X., Wu, Z., Shen, J., & Xu, L. (2012) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155412443542 · Cited by 25
A Role for Sigma Receptors in Stimulant Self-Administration and Addiction
Katz, J. L., Hiranita, T., Hong, W. C., Job, M. O., & McCurdy, C. R. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_94 · Cited by 23
Involvement of Chaperone Sigma1R in the Anxiolytic Effect of Fabomotizole
Воронин, М. В., Vakhitova, Y. V., Tsypysheva, I. P., Tsypyshev, D. O., Rybina, I. V., Kurbanov, R. D., Абрамова, Е. В., & Середенин, С. Б. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115455 · Cited by 22
Trujillo, A. N., Katnik, C. P., Cuevas, J., Jake, B., Taylor‐Clark, T. E., & Breslin, J. W. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00702.2016 · Cited by 20
Parakh, S., & Atkin, J. D. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.02.002 · Cited by 20
Pharmacological and Pathological Implications of Sigma-1 Receptor in Neurodegenerative Diseases
Drewes, N. B., Fang, X., Gupta, N., & Nie, D. (2025) · Biomedicines · doi:10.3390/biomedicines13061409 · Cited by 22
GLP-1/Sigma/RAGE receptors: An evolving picture of Alzheimer's disease pathology and treatment
Neha, N., Wali, Z., Pinky, P., Hattiwale, S. H., Jamal, A., & Parvez, S. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102134 · Cited by 19
DGAT2 stability is increased in response to DGAT1 inhibition in gene edited HepG2 cells
McFie, P. J., Chumala, P., Katselis, G. S., & Stone, S. J. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.158991 · Cited by 18
Pan, L., Pasternak, D. A., Xu, J., Xu, M., Lu, Z., Pasternak, G. W., & Pan, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174694 · Cited by 18
Abdullah, C. S., Aishwarya, R., Alam, S., Remex, N. S., Morshed, M., Nitu, S. S., Miriyala, S., Panchatcharam, M., Hartman, B., King, J., et al. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.12.002 · Cited by 18
A Medicinal‐Chemistry‐Guided Approach to Selective and Druglike Sigma 1 Ligands
Corbera, J., Vaño, D., Martínez, D., Vela, J. M., Zamanillo, D., Dordal, A., Andreu, F., Hernández, E., Perez, R., Escriche, M., et al. (2005) · ChemMedChem · doi:10.1002/cmdc.200500034 · Cited by 18
Sigma-1 receptor as a potential pharmacological target for the treatment of neuropathology
Bolshakova, A. V., Kukanova, E. O., Gainullina, A. N., Zhemkov, V., Korban, S. A., & Борисович, Б. И. (2016) · St Petersburg Polytechnical University Journal Physics and Mathematics · doi:10.1016/j.spjpm.2016.03.003 · Cited by 17
Annexins Bridging the Gap: Novel Roles in Membrane Contact Site Formation
Enrich, C., Lu, A., Tebar, F., Rentero, C., & Grewal, T. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.797949 · Cited by 18
Cagalinec, M., Mohd, A., Borecká, S., Bultynck, G., Choubey, V., Yanovsky‐Dagan, S., Ezer, S., Gašperíková, D., Harel, T., Jurkovičová, D., et al. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2025.119954 · Cited by 15
Roy, J., Kyani, A., Hanafi, M., Xu, Y., Takyi‐Williams, J., Sun, D., Osman, E. E. A., & Neamati, N. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01769 · Cited by 15
Gaining in pan-affinity towards sigma 1 and sigma 2 receptors. SAR studies on arylalkylamines
Rossi, D., Rui, M., Giacomo, M. D., Schepmann, D., Wünsch, B., Monteleone, S., Liedl, K. R., & Collina, S. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.10.005 · Cited by 13
Li, J., Félix‐Soriano, E., Wright, K. R., Shen, H., Baer, L. A., Stanford, K. I., & Guo, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810846 · Cited by 13
Novel sugar-cholestanols as anticancer agents against peritoneal dissemination of tumor cells
Hahismoto, S., Yazawa, S., Asao, T., Faried, A., Nishimura, T., Tsuboi, K., Nakagawa, T., Yamauchi, T., Koyama, N., Umehara, K., et al. (2008) · Glycoconjugate Journal · doi:10.1007/s10719-008-9108-x · Cited by 13
Pati, M. L., Abate, C., Contino, M., Ferorelli, S., Luisi, R., Carroccia, L., Niso, M., & Berardi, F. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.11.001 · Cited by 13
Skuza, G., Sadaj, W., Kabziński, M., Cassano, G., Gasparre, G., Abate, C., & Berardi, F. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2013.12.002 · Cited by 13
Couly, S., Yasui, Y., Foncham, S., Grammatikakis, I., Lal, A., Shi, L., & Su, T. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05023-z · Cited by 13
Self-citationGarcía-Pupo, L., Crouzier, L., Bencomo-Martínez, A., Meunier, J., Morilleau, A., Delprat, B., Sablón-Carrazana, M., Menéndez, R., Maurice, T., & Rodríguez‐Tanty, C. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.06.013 · Cited by 12
Sigma-1 receptor concentration in plasma of patients with late-life depression: a preliminary study
Tani, M., Shimizu, H., Takebayashi, M., Tanaka, H., Yamagata, B., Kurosawa, K., Yamada, H., Hachisu, M., Hisaoka‐Nakashima, K., Okada‐Tsuchioka, M., et al. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s53386 · Cited by 12
Laurini, E., Harel, D., Marson, D., Schepmann, D., Schmidt, T. J., Pricl, S., & Wünsch, B. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.06.054 · Cited by 12
The Effects of Terminal Tagging on Homomeric Interactions of the Sigma 1 Receptor
Yano, H., Liu, L., Naing, S., & Shi, L. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01356 · Cited by 12
Ackerman, W. E., Robinson, J. M., & Kniss, D. A. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5a6710.2005 · Cited by 12
Воронин, М. В., Шангин, С. В., Литвинова, С. А., Абрамова, Е. В., Kurbanov, R. D., Rybina, I. V., Vakhitova, Y. V., & Середенин, С. Б. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119580 · Cited by 11
The Emerging Role of Sigma Receptors in Pain Medicine
Pergolizzi, J. V., & Varrassi, G. (2023) · Cureus · doi:10.7759/cureus.42626 · Cited by 11
Allosteric Modulation of Opioid G-Protein Coupled Receptors by Sigma1 Receptors
Pasternak, G. W. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_34 · Cited by 11
Sigma1 Regulates Lipid Droplet–Mediated Redox Homeostasis Required for Prostate Cancer Proliferation
Oyer, H. M., Steck, A. R., Longen, C. G., Venkat, S., Bayrak, K., Munger, E. B., Fu, D., Castagnino, P. A., Sanders, C. M., Tancler, N. A., et al. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0371 · Cited by 11
Crouzier, L., Meunier, J., Carles, A., Morilleau, A., Vrigneau, C., Schmitt, M., Bourguignon, J., Delprat, B., & Maurice, T. (2023) · Phytotherapy Research · doi:10.1002/ptr.8068 · Cited by 11
Kaushal, N., Robson, M. J., Rosen, A., McCurdy, C. R., & Matsumoto, R. R. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.12.039 · Cited by 10
Андреевич, К. И., Verbovaya, E. R., Воронков, Д. Н., Воронин, М. В., & Середенин, С. Б. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207620 · Cited by 11
What is the role of lipids in prion conversion and disease?
Conceição, C. A., de Lemos, G. A., Barros, C. A., & Vieira, T. C. R. G. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1032541 · Cited by 10
Metadata
- Authors
- Hayashi, T., & Su, T.-P.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Su, Tsung-Ping
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2003-08
- Volume
- 306
- Issue
- 2
- Pages
- 718-725
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2156975935
- Cited by
- 262
- References
- 41
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 6 · 2023: 14 · 2022: 5 · 2021: 25 · 2020: 13 · 2019: 9 · 2018: 6 · 2017: 13 · 2016: 12 · 2015: 12 · 2014: 18 · 2013: 11 · 2012: 12
- FWCI
- 3.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Caveolin-1 and cellular processes
- Keywords
- sigma-1 receptor, lipid rafts, lipid droplets, endoplasmic reticulum, caveolin-2, ADRP, pentazocine, neutral lipids, cholesterol, neurosteroids, NG108-15 cells
- MeSH terms
- Sigma-1 Receptor, Animals, Bacterial Proteins, Binding Sites, Endoplasmic Reticulum, Guinea Pigs, Hybridomas, Intracellular Membranes, Luminescent Proteins, Tumor Cells, Cultured, Protein Structure, Tertiary, Receptors, sigma, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review